Position in GMAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,140,475
+$10,154,797 QoQ
Shares Held
1,279,231
+37.4% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. GMAB ranks #88 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in GMAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,140,475 | 1,279,231 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $24,985,678 | 931,259 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $41,065,732 | 1,333,303 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $34,308,350 | 1,118,629 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $18,372,420 | 889,275 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,869,512 | 708,351 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $16,134,679 | 773,104 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $20,117,059 | 825,146 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,060,419 | 877,852 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $19,601,398 | 655,346 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $16,809,099 | 527,924 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $22,443,499 | 636,334 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $23,456,160 | 617,105 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $30,554,220 | 809,169 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $30,750,630 | 725,593 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $23,752,712 | 739,269 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $16,592,836 | 510,706 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $34,919,777 | 965,168 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $59,544,207 | 1,505,162 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $71,055,893 | 1,625,993 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $71,825,481 | 1,759,135 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $58,387,990 | 1,778,495 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $61,649,138 | 1,516,211 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $35,806,556 | 978,054 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $32,830,462 | 968,736 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,376,285 | 206,526 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||